Skip to main content
OpenTrials

Clinical trial condition

Advanced Cancer

Explore clinical trials studying Advanced Cancer. Study availability and eligibility vary by location and protocol.

455 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Advanced Cancer trial results

Completed

An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

NCT03994601

Conditions
Advanced Cancer
Locations
  • Local Institution - 0075 Costa Mesa, California, United States
  • Local Institution - 0050 Orange, California, United States
  • Local Institution - 0005 Aurora, Colorado, United States
  • Local Institution - 0002 Baltimore, Maryland, United States
View all 40 locations
View Trial Details
Completed

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor

NCT04648254

Conditions
Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Atlantic Health System Hospital Morristown, New Jersey, United States
View Trial Details
Completed

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

NCT03307785

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Encinitas, California, United States
  • GSK Investigational Site San Marcos, California, United States
  • GSK Investigational Site Sarasota, Florida, United States
View Trial Details
Completed

An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer

NCT02743494

Conditions
Advanced Cancer
Locations
  • Local Institution - 0250 Tucson, Arizona, United States
  • Local Institution - 0026 Los Angeles, California, United States
  • Local Institution - 0023 San Francisco, California, United States
  • Local Institution - 0068 San Francisco, California, United States
View all 204 locations
View Trial Details

Related conditions